Thermolaser Medical

We have recognized a novel way to treat age-related macular degeneration (AMD), which is the leading cause of blindness among elderly people. 150 million people worldwide live with AMD, and it has a global public health cost of $350 billion annually. Yet, there is no treatment for the most common form of the disease. Our scientific work has produced a technology (patent pending) that allows us to test the therapy in mice. We are now applying for a Tekes TUTL funding for the next two years to develop a safe treatment device for human patients and to launch a start-up after the project.

Our team consists of two engineers, a biochemist and a professor in biophysics, and our goal is to develop a solution that can prevent visual impairment in millions of AMD patients.